Coated Endotracheal Tube- KBV Research

The Global Coated Endotracheal Tube Market size is expected to reach $2.6 billion by 2024, rising at a market growth of 6.6% CAGR during the forecast period.


Coated endotracheal tube is a specific tube coated with antithrombotic agents that is used to prevent coagulation or antibiotic agents such as polyvinyl chloride, silver, and various drugs to limit the growth of the bacteria on the surface of endotracheal tube. Endotracheal tube is a metal or plastic tube that is introduced in the trachea via the mouth or nose to validate the adequate exchange of oxygen and carbon dioxide and at the same time maintain the patient's airway.


Endotracheal tube needs to be replaced on a regular basis because it causes excessive discomfort to patients. To prevent frequent replacements, tubes are therefore, treated with antibacterial agents. Growing number of surgical procedures due to increasing chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries are the factors that contribute to the growth of the market.


Furthermore, the growing need for ventilator associated pneumonia and growth in geriatric population, that is highly prone to chronic diseases also significantly contribute to the market growth. However, post-operative complications related to endotracheal intubation and lack of skilled professionals are the factors that limit the market growth.


Full Report: https://www.kbvresearch.com/coated-endotracheal-tube-market/

 

The Wall

No comments
You need to sign in to comment